For: | Liu KY, Zhang DB, Wei QK, Li J, Li GP, Yu JZ. Biological role of surface Toxoplasma gondii antigen in development of vaccine. World J Gastroenterol 2006; 12(15): 2363-2368 [PMID: 16688826 DOI: 10.3748/wjg.v12.i15.2363] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i15/2363.htm |
Number | Citing Articles |
1 |
Érica Araújo Mendes, Flavio G. Fonseca, Bárbara M. Casério, Janaína P. Colina, Ricardo Tostes Gazzinelli, Braulia C. Caetano, Mauricio Martins Rodrigues. Recombinant Vaccines against T. gondii: Comparison between Homologous and Heterologous Vaccination Protocols Using Two Viral Vectors Expressing SAG1. PLoS ONE 2013; 8(5): e63201 doi: 10.1371/journal.pone.0063201
|
2 |
Yali Han, Aihua Zhou, Gang Lu, Guanghui Zhao, Wenchao Sha, Lin Wang, Jingjing Guo, Jian Zhou, Huaiyu Zhou, Hua Cong, Shenyi He. DNA Vaccines Encoding Toxoplasma gondii Cathepsin C 1 Induce Protection against Toxoplasmosis in Mice. The Korean Journal of Parasitology 2017; 55(5): 505 doi: 10.3347/kjp.2017.55.5.505
|
3 |
Min Meng, Shenyi He, Guanghui Zhao, Yang Bai, Huaiyu Zhou, Hua Cong, Gang Lu, Qunli Zhao, Xing-Quan Zhu. Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice. Parasites & Vectors 2012; 5(1) doi: 10.1186/1756-3305-5-273
|
4 |
Meng-Yee Lai, Yee-Ling Lau. Screening and identification of host proteins interacting with Toxoplasma gondii SAG2 by yeast two-hybrid assay. Parasites & Vectors 2017; 10(1) doi: 10.1186/s13071-017-2387-y
|
5 |
Seyed Hossein Abdollahi, Fateme Ayoobi, Hossein Khorramdelazad, Behzad Nasiri Ahmadabadi, Mohammadtaghi Rezayati, Mohammad Kazemi Arababadi, Mohammad Zare-Bidaki. Levels of Transforming Growth Factor-Beta After Immunization of Mice With Toxoplasma gondii prepared Excretory/Secretory Proteins. Jundishapur Journal of Microbiology 2015; 8(5) doi: 10.5812/jjm.8(5)2015.17802
|
6 |
Mingfu Xue, Shenyi He, Jie Zhang, Yuling Cui, Yuan Yao, Huaxin Wang. Comparison of cholera toxin A2/B and murine interleukin-12 as adjuvants of Toxoplasma multi-antigenic SAG1-ROP2 DNA vaccine. Experimental Parasitology 2008; 119(3): 352 doi: 10.1016/j.exppara.2008.03.005
|
7 |
Lili Cao, Juan Liu, Songgao Cao, Panpan Zhao, Xingzhong Sun, Hang Dong, Babatunde Kazeem Bello, Yanbing Guo, Nan Wang, Nan Zhang, Ying Li, Xianhe Li, Pengtao Gong. Protective efficacy of Toxoplasma gondii bivalent MAG1 and SAG1 DNA vaccine against acute toxoplasmosis in BALB/c mice. Parasitology Research 2023; 122(3): 739 doi: 10.1007/s00436-022-07745-8
|
8 |
Mingfu Xue, Shenyi He, Yuling Cui, Yuan Yao, Huaxin Wang. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii. Parasitology International 2008; 57(4): 424 doi: 10.1016/j.parint.2008.05.001
|
9 |
Marina Clemente. Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases. 2014; : 215 doi: 10.1007/978-1-4939-0850-9_11
|
10 |
Meng-Yee Lai, Nazia Abdul-Majid, Yee-Ling Lau. Identification of Host Proteins Interacting with Toxoplasma gondii SAG1 by Yeast Two-Hybrid Assay. Acta Parasitologica 2019; 64(3): 575 doi: 10.2478/s11686-019-00066-4
|
11 |
Thais A. Costa-Silva, Cristina S. Meira, Isabelle M.R. Ferreira, Roberto M. Hiramoto, Vera L. Pereira-Chioccola. Evaluation of immunization with tachyzoite excreted–secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii. Experimental Parasitology 2008; 120(3): 227 doi: 10.1016/j.exppara.2008.07.015
|
12 |
Emna Hannachi, Aïda Bouratbine, Mohamed Mousli. Enhancing the detection of Toxoplasma gondii via an anti-SAG1 scFv-alkaline phosphatase immunoconjugate. Biotechnology Reports 2019; 23: e00360 doi: 10.1016/j.btre.2019.e00360
|
13 |
Mona H. El-Sayad, Neveen A. Hussein, A. H. Kazem, Omnya A. El Geddawi, Enas M. Rizk, Hend A. El-Taweel. Temporal expression of Toxoplasma stage-specific genes in brain tissue: coincidence with parasitological and histopathological findings in mice models. Parasitology Research 2020; 119(7): 2299 doi: 10.1007/s00436-020-06723-2
|
14 |
Fatemeh Rezaei, Shahabeddin Sarvi, Mahdi Sharif, Seyed Hossein Hejazi, Abdol sattar Pagheh, Sargis A. Aghayan, Ahmad Daryani. A systematic review of Toxoplasma gondii antigens to find the best vaccine candidates for immunization. Microbial Pathogenesis 2019; 126: 172 doi: 10.1016/j.micpath.2018.11.003
|
15 |
Sherene Swee Yin Lim, Kek Heng Chua, Greta Nölke, Holger Spiegel, Wai Leong Goh, Sek Chuen Chow, Boon Pin Kee, Rainer Fischer, Stefan Schillberg, Rofina Yasmin Othman. Plant-derived chimeric antibodies inhibit the invasion of human fibroblasts byToxoplasma gondii. PeerJ 2018; 6: e5780 doi: 10.7717/peerj.5780
|
16 |
Jian Zhou, Lin Wang. SAG4 DNA and Peptide Vaccination Provides Partial Protection against T. gondii Infection in BALB/c Mice. Frontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.01733
|
17 |
Yong-Feng Fu, Meng Feng, Kenji Ohnishi, Tamon Kimura, Johbu Itoh, Xun-Jia Cheng, Hiroshi Tachibana, J. H. Adams. Generation of a Neutralizing Human Monoclonal Antibody Fab Fragment to Surface Antigen 1 ofToxoplasma gondiiTachyzoites. Infection and Immunity 2011; 79(1): 512 doi: 10.1128/IAI.00969-10
|
18 |
Rasha F. Mady, Wessam El-Hadidy, Samar Elachy. Effect of Nigella sativa oil on experimental toxoplasmosis. Parasitology Research 2016; 115(1): 379 doi: 10.1007/s00436-015-4759-6
|
19 |
Yali Han, Aihua Zhou, Gang Lu, Guanghui Zhao, Lin Wang, Jingjing Guo, Pengxia Song, Jian Zhou, Huaiyu Zhou, Hua Cong, Shenyi He. Protection via a ROM4 DNA vaccine and peptide against Toxoplasma gondii in BALB/c mice. BMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-016-2104-z
|
20 |
Jian Zhou, Wanchun Wang, Pengxia Song, Lin Wang, Yali Han, Jingjing Guo, Zhen Hao, Xi Zhu, Qiong Zhou, Xiadong Du, Gang Lu, Shenyi He, Yingquan Luo. Structural predication and antigenic analysis of Toxoplasma gondii ROP20. Acta Parasitologica 2018; 63(2): 244 doi: 10.1515/ap-2018-0028
|
21 |
K. Hoseinian Khosroshahi, F. Ghaffarifar, S. D'Souza, Z. Sharifi, A. Dalimi. Evaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosis. Vaccine 2011; 29(4): 778 doi: 10.1016/j.vaccine.2010.11.012
|
22 |
S. J. Goodswen, P. J. Kennedy, J. T. Ellis. A guide to in silico vaccine discovery for eukaryotic pathogens. Briefings in Bioinformatics 2013; 14(6): 753 doi: 10.1093/bib/bbs066
|
23 |
Jian Zhou, Gang Lu, Lin Wang, Aihua H. Zhou, Yali L. Han, Jingjing J. Guo, Pengxia X. Song, Huaiyu Y. Zhou, Hua Cong, Ming Hou, Shenyi Y. He. Structuraland antigenic analysis of a new Rhoptry Pseudokinase Gene (ROP54) in Toxoplasma gondii. Acta Parasitologica 2017; 62(3) doi: 10.1515/ap-2017-0061
|